How to buy LivaNova stock (LIVN)

LivaNova is a medical devices business based in the US. LivaNova shares (LIVN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $46.56 – a decrease of 2.16% over the previous week. LivaNova employs 2,900 staff and has a trailing 12-month revenue of around $1.2 billion.

Our top picks for where to buy LivaNova stock

Buy LivaNova stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

LivaNova stock price (NASDAQ: LIVN)

Use our graph to track the performance of LIVN stocks over time.

LivaNova shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$46.56
52-week range	$43.15 - $64.48
50-day moving average more info button	$51.35
200-day moving average more info button	$52.78
Wall St. target price	$69.09
PE ratio more info button	108.7209
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$0.43

Is it a good time to buy LivaNova stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LivaNova price performance over time

Historical closes compared with the close of $46.56 from 2024-12-27

1 week (2024-12-20)	-2.16%
1 month (2024-11-29)	-11.31%
3 months (2024-09-27)	-11.35%
6 months (2024-06-28)	-15.07%

1 year (2023-12-29)	-10.01%
2 years (2022-12-29)	-16.38%
3 years (2021-12-29)	87.8
5 years (2019-12-27)	75.4

Is LivaNova stock undervalued or overvalued?

Valuing LivaNova stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LivaNova's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LivaNova's P/E ratio

LivaNova's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 109x. In other words, LivaNova shares trade at around 109x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LivaNova's PEG ratio

LivaNova's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4425. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LivaNova's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LivaNova's EBITDA

LivaNova's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $212.6 million.

The EBITDA is a measure of a LivaNova's overall financial performance and is widely used to measure a its profitability.

LivaNova financials

Revenue TTM	$1.2 billion
Operating margin TTM	14.09%
Gross profit TTM	$696.7 million
Return on assets TTM	4.34%
Return on equity TTM	1.87%
Profit margin	1.91%
Book value	$24.13
Market Capitalization more info button	$2.5 billion

TTM: trailing 12 months

LivaNova share dividends

We're not expecting LivaNova to pay a dividend over the next 12 months.

LivaNova share price volatility

Over the last 12 months, LivaNova's shares have ranged in value from as little as $43.15 up to $64.475. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LivaNova's is 1.009. This would suggest that LivaNova's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

LivaNova overview

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors.

Frequently asked questions

What percentage of LivaNova is owned by insiders or institutions?
Currently 0.334% of LivaNova shares are held by insiders and 101.268% by institutions. How many people work for LivaNova?
Latest data suggests 2,900 work at LivaNova. When does the fiscal year end for LivaNova?
LivaNova's fiscal year ends in December. Where is LivaNova based?
LivaNova's address is: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG What is LivaNova's ISIN number?
LivaNova's international securities identification number is: GB00BYMT0J19 What is LivaNova's CUSIP number?
LivaNova's Committee on Uniform Securities Identification Procedures number is: G5509L101